The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Endogenous Cushing’s syndrome (CS) is associated with significant psychopathology during the course of the disease. The purpose of this study was to evaluate the psychological and endocrine status of patients with CS after correction of their hypercortisolism. Thirty-three patients with active CS were examined before and at 3 months (28 patients), 6 months (25 patients), and 12 months (29 patients) after correction of hypercortisolism. Before cure, 66.7% of the patients had significant psychopathology, with the predominant diagnosis of atypical depressive disorder (AD) in 51.5% and/or major affective disorder in 12%. After cure, overall psychopathology decreased significantly to 53.6% at 3 months, 36% at 6 months, and 24.1% at 12 months, when there was a parallel recovery of the hypothalamic-pituitary-adrenal axis assessed by serial morning ACTH stimulation tests. There was an inverse correlation between psychological recovery and baseline morning cortisol, but no correlation with ACTH-stimulated cortisol values at 60 min. AD continued to be the prevailing diagnosis after correction of hypercortisolism, whereas the frequency of suicidal ideation and panic increased. The presence of AD before and after correction of hypercortisolism might be due to glucocorticoid-induced suppression of hypothalamic CRH secretion. The slight increase in the incidence of panic after correction of hypercortisolism might be due to a decreased glucocorticoid restraint at the central arousal/sympathetic catecholaminergic system. We conclude that CS is associated with AD symptomatology, which gradually improves with time after correction of hypercortisolism. Health care providers should be aware of changes in symptomatology, including suicidal ideation and panic attacks, that occur in a subgroup of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GWS occurs due to a relative decrease in cortisol concentrations after surgical cure, and consists not only of physical signs and symptoms, but also psychiatric symptoms (such as depression and anxiety), which affect recovery and overall quality of life24,25.”
From Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess (2018) · cites this paper as [24]
Citations
Cites
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398 · cited 1×
“Interrater agreement on the presence or absence of a psychiatric diagnosis was made on approximately 32% of the posttreatment interviews throughout the course of the study. The average k coefficient ( 22 ) was 0.87.”
BackgroundInfluential(1970) · Cited by 24,983
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 3×
“In an earlier report we showed that over 50% of patients with active CS present with symptoms of atypical depression (6), a phenomenon compatible with the fact that patients with active CS exhibit glucocorticoid-induced suppression of their CRH neurons ( 9 , 10, 17).”
BackgroundResultInfluentialSelf-citationWilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115 · cited 1×
“The Hamilton Rating Scale for Depression ( 24 ) consists of 21 items and yields scores of depression severity from 0‐65.”
MethodDEMITRACK, M. A., DALE, J. K., STRAUS, S. E., LAUE, L., LISTWAK, S. J., KRUESI, M. J. P., CHROUSOS, G. P., & GOLD, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1224 · Cited by 727 · cited 1×
“To date, the coexistence of atypical depression and low hypothalamic CRH secretion has been shown or inferred in patients with active CS (10), seasonal affective disorder (11), the chronic fatigue/fibromyalgia syndromes ( 12 , 13), and the postpartum blues/depression syndromes (14).”
BackgroundSelf-citationHypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia
Crofford, L. J., Pillemer, S. R., Kalogeras, K. T., Cash, J. M., Michelson, D., Kling, M. A., Sternberg, E. M., Gold, P. W., Chrousos, G. P., & Wilder, R. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371105 · Cited by 508 · cited 1×
“To date, the coexistence of atypical depression and low hypothalamic CRH secretion has been shown or inferred in patients with active CS (10), seasonal affective disorder (11), the chronic fatigue/fibromyalgia syndromes (12, 13 ), and the postpartum blues/depression syndromes (14).”
BackgroundSelf-citationKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050025004 · Cited by 323
Risk factors and long-term outcome in pituitary-dependent Cushing's disease
Sonino, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2647 · Cited by 265 · cited 1×
“Others reported that postoperative depression was a predictor of both nonremission and relapse after pituitary surgery of Cushing’s disease ( 33 ).”
BackgroundPhenelzine v Imipramine in Atypical Depression: A Preliminary Report
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790180039005 · Cited by 261
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.1.52 · Cited by 247
Research works printed but not linked: 4
- Gifford, 1970, 49, 397
- Kelly, 1983, 142, 16
- Munabi, 1986, 63, 1036
- Endicott, 1979, 136, 52
Cited by
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
“Successful medical inhibition of steroid production generally improves depressive as well as other disabling psychological symptoms (60, 63, 64).”
BackgroundSelf-citationTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
“Adults may experience persistent or new-onset atypical depressive disorders, anxiety, or panic symptoms (82).”
BackgroundThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“However, it should be noted that also after correction of the hypercortisolism in Cushing’s syndrome, atypical depression frequently continues to be present and suicidal ideation and panic may even increase (Dorn et al., 1997).”
BackgroundCHROUSOS, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09006.x · Cited by 711
Self-citationChrousos, G. P., Torpy, D. J., & Gold, P. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-3-199808010-00012 · Cited by 706
“Although several depressive conditions, such as melancholic depression and anorexia nervosa, are typically associated with high hypothalamic CRH secretion, other states, such as atypical or seasonal depression, the chronic fatigue and fibromyalgia syndromes, and the Cushing syndrome before and during the first year af…”
BackgroundSelf-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
“However, it should be noted that after correction of the hypercortisolism in Cushing's syndrome, atypical depression frequently continues to be present and suicidal ideation and panic may even increase (Dorn et al., 1997).”
BackgroundThe Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
James, K. A., Stromin, J. I., Steenkamp, N., & Combrinck, M. I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085950 · Cited by 364
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318
“…and have consistently been shown to be associated with significant neurocognitive impairment (Forget et al, 2000; Mauri et al, 1993; Starkman et al, 2001; Whelan et al, 1980) and a high incidence of depression, which notably resolves with correction of the hypercortisolaemia (Dorn et al, 1997).”
BackgroundSonino, N., & Fava, G. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00003 · Cited by 267
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253
“Similarly, disappearance of psychological distress does not always occur upon proper endocrine treatment (2).”
BackgroundBourdeau, I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1949 · Cited by 239
“Further studies will be necessary to determine whether complete reversal of brain volume loss is possible and whether these observations correlate with neuropsychological improvement (1, 40).”
BackgroundWebb, S. M., Badia, X., Barahona, M. J., Colao, A., Strasburger, C. J., Tabarin, A., van Aken, M. O., Pivonello, R., Stalla, G., Lamberts, S. W. J., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0762 · Cited by 229
“In this multinational study, CushingQoL scored worse in patients with recent hospital admission and diagnosed in the prior 2 years, when all had experienced hypercortisolism, a situation previously described as associated with impaired perception of QoL (1, 8, 9 , 15).”
BackgroundInfluentialDu, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 205
“Three months following treatment for hypercortisolemia, this dropped significantly to 54% and further decreased to 24% 12 months after correction (61).”
BackgroundLindsay, J. R., Nansel, T., Baid, S., Gumowski, J., & Nieman, L. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1058 · Cited by 210
“1% at 12 months of recovery from hypercortisolism (9).”
BackgroundAltered salivary dehydroepiandrosterone levels in major depression in adults
Michael, A., Jenaway, A., Paykel, E. S., & Herbert, J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00955-0 · Cited by 206
Successful Long-Term Treatment of Refractory Cushing's Disease with High-Dose Mifepristone (RU 486)
Chu, J. W. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3568 · Cited by 200
“The association between hypercortisolism and neuropsychiatric symptoms has been known for decades, with an estimated prevalence of psychiatric dysfunction of more than 40% in patients with CS (19).”
BackgroundPredictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients
Lambert, J. K., Goldberg, L., Fayngold, S., Kostadinov, J., Post, K. D., & Geer, E. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2893 · Cited by 186
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., De Martino, M. C., Cozzolino, A., De Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 174
Endocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181
Self-citationNeuropsychiatric Disorders in Cushing’s Syndrome
Pereira, A. M., Tiemensma, J., & Romijn, J. A. (2010) · Neuroendocrinology · doi:10.1159/000314317 · Cited by 145
“Intriguingly, even after correction of hypercortisolism, atypical depressive disorder continued to be the prevailing diagnosis, whereas the frequency of suicidal ideation and panic disorder increased (15).”
BackgroundGlucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168
“Guido Di Dalmazi, Uberto Pagotto, Renato Pasquali, and Valentina Vicennati Division of Endocrinology, Department of Medical and Surgical Science, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, Italy Correspondence should be addressed to Valentina Vicennati, vicennati@aos…”
MethodInnovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 171
“Improvement in mood is often observed in Cushing’s disease patients upon successful treatment of their hypercortisolemia [115].”
BackgroundDiagnosis and Treatment of Pituitary Tumors
Freda, P. U. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.3859 · Cited by 158
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Medical Treatment of Cushing's Disease
Feelders, R. A., & Hofland, L. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3126 · Cited by 143
“Finally, psychopathology can decrease after curation in a time-dependent manner (32), although its prevalence is still increased after long-term remission (14).”
BackgroundTiemensma, J., Biermasz, N. R., Middelkoop, H. A. M., van der Mast, R. C., Romijn, J. A., & Pereira, A. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0512 · Cited by 142
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundResultResidual symptoms in depression
Fava, G. A., Fabbri, S., & Sonino, N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00226-9 · Cited by 137
Persistent cognitive impairment following surgical treatment of Cushing's syndrome
Forget, H., Lacroix, A., & Cohen, H. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00059-2 · Cited by 151
“A more recent study showed that the incidence of atypical depression progressively decreased after correction of hypercortisolism — this disorder, however, continued to be the prevailing psychiatric diagnosis after the successful cure of CS (Dorn et al., 1997).”
BackgroundOverall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
Ragnarsson, O., Olsson, D. S., Papakokkinou, E., Chantzichristos, D., Dahlqvist, P., Segerstedt, E., Olsson, T., Petersson, M., Berinder, K., Bensing, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02524 · Cited by 134
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
Vives, A. S., Resmini, E., Pascual, J. C., Crespo, I., & Webb, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0735-z · Cited by 146
Merke, D. P., Giedd, J. N., Keil, M. F., Mehlinger, S. L., Wiggs, E. A., Holzer, S., Rawson, E., Vaituzis, A. C., Stratakis, C. A., & Chrousos, G. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2488 · Cited by 128
Self-citationO’Keane, V., Frodl, T., & Dinan, T. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.009 · Cited by 140
“Approximately 60% of patients with Cushing’s Syndrome have depression with a predominant diagnosis (77%) of atypical subtype (Dorn et al., 1997).”
BackgroundCushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
Barbot, M., Zilio, M., & Scaroni, C. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101380 · Cited by 116
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
“Psychopathology (15, 16) and fatigue (17, 18) are com-”
BackgroundO’Keane, V., Dinan, T. G., Scott, L., & Corcoran, C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.049 · Cited by 111
Comorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 101
“Overall psychopathology 67 % [42, 45]”
BackgroundPsychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. A. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 122
“Manic and hypomanic symptoms may be among the early manifestations of illness [38, 45].”
BackgroundAlkemade, A., Unmehopa, U. A., Wiersinga, W. M., Swaab, D. F., & Fliers, E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1430 · Cited by 101
“This decrease in TRH mRNA may be of importance in the pathogenesis of depression, which is often seen in patients treated with corticosteroids (28) and patients with Cushing’s syndrome (29, 30).”
BackgroundEwald, E. R., Wand, G. S., Seifuddin, F., Yang, X., Tamashiro, K. L., Potash, J. B., Zandi, P., & Lee, R. S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.003 · Cited by 105
“Notably, the psychiatric symptoms are often alleviated with resolution of hypercortisolemia, strongly suggesting involvement of glucocorticoids in depressive symptoms (Starkman et al., 1986, Dorn et al., 1997).”
BackgroundAndela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van den Berg, S. M., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Romijn, J. A., Tiemensma, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0471 · Cited by 102
Mainio, A., Hakko, H. H., Niemelä, A., Koivukangas, J. P., & Räsänen, P. K. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.5.0841 · Cited by 103
Yang, X., Ewald, E. R., Huo, Y., Tamashiro, K. L., Salvatori, R., Sawa, A., Wand, G. S., & Lee, R. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.035 · Cited by 97
“Remarkably, up to 60~90% of patients with endogenous CS develop depression [1,2,3], and the depressive symptoms often disappear with resolution of hypercortisolemia [2,4].”
BackgroundPersistent Psychological Distress in Patients Treated for Endocrine Disease
Sonino, N., Navarrini, C., Ruini, C., Ottolini, F., Paoletta, A., Fallo, F., Boscaro, M., & Fava, G. A. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000075538 · Cited by 95
“In the present population of remitted patients (n = 18), major depression was found in 3 (17p). In a study of the longitudinal course of psychiatric symptoms in Cushing’s syndrome after correction of hypercortisolism [”
BackgroundEvaluation of depression, quality of life and body image in patients with Cushing’s disease
Alçalar, N., Ozkan, S., Kadıoğlu, P., Celik, O., Çağatay, P., Küçükyürük, B., & Gazioğlu, N. (2012) · Pituitary · doi:10.1007/s11102-012-0425-5 · Cited by 95
“In another study showed that significant improvement of psychopathology in patients with CS after successful surgical treatment, parallel with morning cortisol levels [29].”
BackgroundBilateral Adrenalectomy for Refractory Cushing Disease: A Safe and Definitive Therapy
Smith, P. W., Turza, K. C., Carter, C. O., Vance, M. L., Laws, E. R., & Hanks, J. B. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.02.054 · Cited by 87
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 93
“Although psychiatric disorders present in CS include also anxiety disorders, mania, and hypomanic episodes (141, 142), the most important and life-threatening psychiatric complication is major depression (1).”
Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration
Starkman, M. N. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.010 · Cited by 101
Cushing's syndrome: aftermath of the cure
Pivonello, R., De Martino, M. C., De Leo, M., Tauchmanovà, L., Faggiano, A., Lombardi, G., & Colao, A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800025 · Cited by 85
Environmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis
Lee, R. S., & Sawa, A. (2014) · Neuroendocrinology · doi:10.1159/000369585 · Cited by 79
Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression
Swaab, D. F., Fliers, E., Hoogendijk, W. J. G., Veltman, D. J., & Zhou, J. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26025-1 · Cited by 87
Hurtado, M. D., Cortes, T., Natt, N., Young, W. F., & Bancos, I. (2018) · Clinical Endocrinology · doi:10.1111/cen.13803 · Cited by 76
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 78
“Some studies have reported both cognitive and brain morphological improvement following treatment [85–89].”
BackgroundCognitive Function and Cerebral Assessment in Patients Who Have Cushing's Syndrome
Bourdeau, I., Bard, C., Forget, H., Boulanger, Y., Cohen, H., & Lacroix, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.016 · Cited by 86
Investigation of Cortisol Levels in Patients with Anxiety Disorders: A Structured Review
Elnazer, H. Y., & Baldwin, D. S. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_299 · Cited by 81
Psychiatric and neurocognitive consequences of endogenous hypercortisolism
Piasecka, M., Papakokkinou, E., Valassi, E., Vives, A. S., Webb, S. M., de Vries, F., Pereira, A. M., & Ragnarsson, Ó. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13056 · Cited by 78
Psychosomatic Aspects of Cushing’s Disease
Sonino, N., & Fava, G. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012274 · Cited by 73
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
He, X., Findling, J. W., & Auchus, R. J. (2022) · Pituitary · doi:10.1007/s11102-022-01218-y · Cited by 64
Ortiz, J. B., & Conrad, C. D. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.005 · Cited by 80
Personality characteristics and quality of life in patients treated for Cushing's syndrome
Sonino, N., Bonnini, S., Fallo, F., Boscaro, M., & Fava, G. A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02462.x · Cited by 69
Chronic glucocorticoid hypersecretion in Cushing’s syndrome exacerbates cognitive aging
Michaud, K., Forget, H., & Cohen, H. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2009.02.013 · Cited by 82
“Given that depression may interfere with the normal expression of cognitive abilities (Christensen, Griffiths, Marckinnon, & Jacomb, 1997; King & Caine, 1996) and is also a hallmark symptom of CS (Dorn et al., 1997; Sonino & Fava, 2001), it is essential to tease out the contribution of GC exposure from those due to de…”
Valassi, E., Feelders, R., Maiter, D., Chanson, P., Yaneva, M., Reincke, M., Krsek, M., Tóth, M., Webb, S. M., Santos, A., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13600 · Cited by 59
Korbonits, M., Blair, J., Bogusławska, A., Ayuk, J., Davies, J. H., Druce, M. R., Evanson, J., Flanagan, D., Glynn, N., Higham, C., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00949-7 · Cited by 71
“Studies of adult patients with Cushing syndrome have reported brain atrophy, cognitive impairment and psychological disease, most commonly depression, associated with excess endogenous circulating glucocorticoids 133 .”
Fleseriu, M., Molitch, M. E., Gross, C., SCHTEINGART, D. E., Vaughan, T. B., & Biller, B. M. K. (2013) · Endocrine Practice · doi:10.4158/ep12149.ra · Cited by 66
Aerobic Physical Exercise as a Possible Treatment for Neurocognitive Dysfunction in Bipolar Disorder
Kucyi, A., Alsuwaidan, M. T., Liauw, S. S., & McIntyre, R. S. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2228 · Cited by 63
Clinical consequences of Cushing’s syndrome
Valassi, E., Crespo, I., Vives, A. S., & Webb, S. M. (2012) · Pituitary · doi:10.1007/s11102-012-0394-8 · Cited by 65
“Additionally, disappearance of psychological distress does not always occur upon proper endocrine treatment [48].”
BackgroundMANAGEMENT OF ENDOCRINE DISEASE: Paediatric Cushing's disease
Storr, H. L., & Savage, M. O. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0013 · Cited by 62
Watson, S., Thompson, J. M., Ritchie, J. C., Nicol Ferrier, I., & Young, A. H. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00280.x · Cited by 58
McGirr, A., Diaconu, G., Berlim, M. T., & Turecki, G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.050 · Cited by 60
“Moreover, in a series of such patients undergoing treatment, suicidality only appeared after the initiation of treatment and biochemical analyses revealed that levels of cortisol were falling (Dorn et al., 1997).”
BackgroundPituitary adenomas and neuropsychological status: a systematic literature review
Pertichetti, M., Serioli, S., Belotti, F., Mattavelli, D., Schreiber, A., Cappelli, C., Padovani, A., Gasparotti, R., Nicolai, P., Fontanella, M. M., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01134-z · Cited by 60
“[27, 45, 47] CD patients show a distinct pattern of personality traits associated with high anxiety in combination with low externalizing behavior, comparable with acromegalic patients, but only in part with NFPA patients.”
ResultKeil, M. F., Merke, D. P., Gandhi, R., Wiggs, E. A., Obunse, K., & Stratakis, C. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03515.x · Cited by 58
Ragnarsson, O., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
Hair Cortisol Concentration as a Biomarker of Sleep Quality and Related Disorders
Mlili, N. E., Ahabrach, H., & Cauli, O. (2021) · Life · doi:10.3390/life11020081 · Cited by 60
“These results suggest a relationship between elevated cortisol and psychopathological disorders [11].”
BackgroundPainovich, J., SHUFELT, C. L., Azziz, R., Yang, Y., Goodarzi, M. O., Braunstein, G. D., Karlan, B. Y., Stewart, P. M., & Merz, C. N. B. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821f9171 · Cited by 53
Psychiatric symptoms as a clinical presentation of Cushing’s syndrome
Tang, A., O’Sullivan, A., Diamond, T., Gerard, A., & Campbell, P. R. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-23 · Cited by 49
“One year post-cure, overall psychopathology improved to 24% of the subjects with atypical depressive disorder remaining the most common diagnosis [7].”
BackgroundPacak, K., Tjurmina, O., Palkovits, M., Goldstein, D. S., Koch, C. A., Hoff, T., & Chrousos, G. P. (2002) · Neuroendocrinology · doi:10.1159/000064522 · Cited by 46
Self-citationGallagher, P., & Young, A. H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a811 · Cited by 47
“…and in conditions associated with a chronic elevation of endogenous cortisol levels, for example Cushing’s disease (Starkman et al 2001; Forget et al 2002), which is also associated with a high incidence of depression that notably resolves with correction of the hypercortisolemia (Dorn et al 1997).”
Cognitive Function in Patients with Cushing Syndrome: A Longitudinal Perspective
Dorn, L. D., & Cerrone, P. (2000) · Clinical Nursing Research · doi:10.1177/10547730022158672 · Cited by 46
“Higher scores on both the POMS and the SCL-90R indicate more depressive symptoms.”
BackgroundMethodResultInfluentialSelf-citationGlucocorticoid withdrawal syndrome: what to expect and how to manage
Theiler‐Schwetz, V., & Prete, A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000804 · Cited by 48
“After successful surgery of endogenous CS, the frequency of atypical depression decreases but continues to be the prevailing diagnosis, whereas the frequency of suicidal ideation and panic increases [21,28].”
BackgroundLong-term cognitive effects of glucocorticoid excess in Cushing’s syndrome
Forget, H., Lacroix, A., Bourdeau, I., & Cohen, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.020 · Cited by 52
Psychological aspects of endocrine disease
Sonino, N., & Fava, G. A. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00528.x · Cited by 44
Chan, L. F., Storr, H. L., Plowman, P. N., Perry, L. A., BESSER, G. M., Grossman, A. B., & Savage, M. O. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0588 · Cited by 43
“Symptoms vary from failing social and interpersonal relationships, anxiety, irritability and demoralisation, to deterioration in school performance in children (7, 35 , 36).”
BackgroundThe degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome
Guarnotta, V., Amato, M. C., Pivonello, R., Arnaldi, G., Ciresi, A., Trementino, L., Citarrella, R., Iacuaniello, D., Michetti, G., Simeoli, C., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0914-9 · Cited by 45
Broersen, L. H. A., Andela, C. D., Dekkers, O. M., Pereira, A. M., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01054 · Cited by 42
Dimopoulou, C., Ising, M., Pfister, H., Schopohl, J., Stalla, G. K., & Sievers, C. (2012) · Neuroendocrinology · doi:10.1159/000338408 · Cited by 41
Khiat, A., Bard, C., Lacroix, A., Rousseau, J., & Boulanger, Y. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199910)12:6<357::aid-nbm584>3.0.co;2-u · Cited by 47
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 45
Valassi, E., Crespo, I., Keevil, B. G., Aulinas, A., Urgell, E., Vives, A. S., Trainer, P. J., & Webb, S. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0779 · Cited by 46
Milian, M., Teufel, P., Honegger, J. B., Gallwitz, B., Schnauder, G., & Psaras, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04191.x · Cited by 38
Pediatric Cushing's syndrome: clinical features, diagnosis, and treatment
Chan, L. F., Storr, H. L., Grossman, A. B., & Savage, M. O. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800012 · Cited by 40
Health-Related Quality of Life in Pituitary Diseases
Crespo, I., Valassi, E., Vives, A. S., & Webb, S. M. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.013 · Cited by 37
Milian, M., Teufel, P., Honegger, J. B., Gallwitz, B., Schnauder, G., & Psaras, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04280.x · Cited by 37
Chrousos, G. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401671101 · Cited by 37
Self-citationChan, L. F., Vaidya, M., Westphal, B., Allgrove, J., Martin, L., Afshar, F., Hindmarsh, P. C., Savage, M. O., Grossman, A. B., & Storr, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324419 · Cited by 37
Quality of life in Cushing’s syndrome
Bride, M. M., Crespo, I., Webb, S. M., & Valassi, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101505 · Cited by 36
Metadata
- Authors
- Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P.
- Affiliations
- University of Pittsburgh (US)
- Brown University (US)
- Cedars-Sinai Medical Center (US)
- the Departments of Behavioral Pediatrics (B.D.), Bethesda, Maryland 20892;
- National Institute of Mental Health (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- Corresponding author
- Dorn, Lorah D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-03-01
- Volume
- 82
- Issue
- 3
- Pages
- 912-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022989916
- Cited by
- 260
- References
- 31
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 11 · 2019: 8 · 2018: 15 · 2017: 11 · 2016: 10 · 2015: 16 · 2014: 12 · 2013: 20 · 2012: 14
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, hypercortisolism, psychopathology, major affective disorders, hypothalamic-pituitary-adrenal axis, ACTH stimulation test, morning cortisol, suicidal ideation, panic attacks, longitudinal course
- MeSH terms
- Adrenalectomy, Adult, Mental Disorders, Cushing Syndrome, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Longitudinal Studies, Male, Medical Records, Middle Aged, Pituitary-Adrenal System, Postoperative Complications, Prospective Studies, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.